Diclofenac Sodium/Lidocaine Hydrochloride

双氯芬酸钠/盐酸利多卡因

Report date: 2022/03/02 16:54:42

Base Information

Drug NameDiclofenac Sodium/Lidocaine Hydrochloride
Drug Alias Name复方双氯芬酸钠盐酸利多卡因注射液
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsSodium channel alpha subunit blockers
TargetsCyclooxygenasesSodium channel alpha subunit
Therapy Area/IndicationsRheumatic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsRheumatic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A